磁种子与导丝乳腺癌定位联合磁性淋巴结检测的成本最小化分析
该研究为一项实用型随机对照试验的预设卫生经济学分析,纳入426例不可触及乳腺癌患者,随机接受磁种子或导丝定位,前哨淋巴结检测采用超顺磁性氧化铁纳米颗粒实现全磁 approach。未调整分析显示两组增量成本无差异,但调整分析显示磁种子组成本降低391欧元(95%CI -422至-360,P=0.002),相当于降低11.1%。结论认为尽管磁种子设备成本较高,但可缩短定位和手术时间、简化流程,从而实现增量成本控制。
要点
- 磁种子定位联合磁性前哨淋巴结检测不增加总体成本。
- 调整分析显示磁种子组成本降低11.1%,主要因流程优化。
- 未调整分析中两组成本差异无统计学意义。
核心结论
- 在预设卫生经济学分析中,磁种子定位联合磁性前哨淋巴结检测可实现增量成本控制,尽管设备成本较高。
- 成本降低归因于更短的定位时间、更短的手术时间和流程简化。
研究设计与样本
- 实用型随机对照试验的预设卫生经济学分析,纳入426例不可触及乳腺癌患者。
- 患者中位年龄65岁(IQR 56-71),中位BMI 26.6(IQR 24.0-29.8)kg/m2,中位肿瘤大小11(IQR 8-15)mm。
- 随机分为磁种子定位组或导丝定位组,前哨淋巴结检测均使用超顺磁性氧化铁纳米颗粒。
- 从医疗系统角度进行成本最小化分析,包括未调整和调整分析。
主要发现
- 未调整分析:导丝组成本3337欧元,磁种子组3274欧元,差异-63欧元(95%CI -302至174),P=0.599。
- 调整分析(包括标记物、乳腺手术类型、单次病灶和前哨淋巴结定位):导丝组3514欧元,磁种子组3123欧元,差异-391欧元(95%CI -422至-360),P=0.002。
- 调整分析对应成本降低11.1%。
- 敏感性分析未改变结果方向。
临床怎么用
- 对于不可触及乳腺癌,磁种子定位联合磁性前哨淋巴结检测可作为导丝定位的替代方案,有助于成本控制。
- 临床决策时可考虑磁种子定位缩短定位和手术时间、简化流程的优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Magnetic seeds have comparable performance to guidewires in breast lesion localization with the advantages of shorter operating time, facilitated logistics, and higher staff satisfaction. However, the high cost of the device remains a concern and warrants health economic evaluation. METHODS: This is a predefined health economic analysis of a pragmatic RCT including 426 patients (median age of 65 (interquartile range (i.q.r.) 56-71) years, median BMI of 26.6 (i.q.r. 24.0-29.8) kg/m2, and a median tumour size of 11 (i.q.r. 8-15) mm) with non-palpable breast cancer, randomized to localization of the tumour with either a magnetic seed or a guidewire. Sentinel lymph node detection was performed using superparamagnetic iron oxide nanoparticles, enabling a totally magnetic approach. A cost-minimization analysis was conducted, from a healthcare system perspective, using unadjusted and adjusted analyses of costs. RESULTS: The unadjusted analysis did not show any difference in incremental costs (guidewire €3337 versus magnetic seed €3274; difference -€63 (95% c.i. -€302 to €174); P = 0.599). The adjusted analysis, including marker, type of breast surgery performed, and single-session lesion and SLN localization, showed that the magnetic seed was associated with reduced costs (guidewire €3514 versus magnetic seed €3123; difference -€391 (95% c.i. -€422 to -€360); P = 0.002), corresponding to a 11.1% reduction. Sensitivity analyses did not change direction of outcome. CONCLUSION: In this predefined health economic analysis of an RCT, the use of magnetic seeds resulted in incremental cost containment, despite the increased cost of the device. Contributing factors included shorter localization time, shorter operating time, and process streamlining.
引用
- Pantiora E, Sampaio F, Jazrawi A, et al. Magnetic seed versus guidewire-based breast cancer localization with magnetic lymph node detection: cost-minimization analysis. Br J Surg. 2025. PMID: 41324549. doi:10.1093/bjs/znaf253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。